X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (27) 27
microbiology (25) 25
animals (18) 18
viruses (18) 18
human necessities (17) 17
humans (17) 17
hygiene (17) 17
medical or veterinary science (17) 17
preparations for medical, dental, or toilet purposes (17) 17
infectious diseases (13) 13
biochemistry (12) 12
virology (12) 12
beer (11) 11
cercopithecus aethiops (11) 11
chemistry (11) 11
compositions or test papers therefor (11) 11
condition-responsive control in microbiological orenzymological processes (11) 11
ebola virus (11) 11
enzymology (11) 11
immunology (11) 11
measuring or testing processes involving enzymes, nucleicacids or microorganisms (11) 11
metallurgy (11) 11
mutation or genetic engineering (11) 11
processes of preparing such compositions (11) 11
spirits (11) 11
testing (11) 11
vero cells (11) 11
vinegar (11) 11
wine (11) 11
agriculture (10) 10
animal husbandry (10) 10
biocides, e.g. as disinfectants, as pesticides, as herbicides (10) 10
compositions thereof (10) 10
culture media (10) 10
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (10) 10
fishing (10) 10
forestry (10) 10
hunting (10) 10
investigating or analysing materials by determining theirchemical or physical properties (10) 10
measuring (10) 10
microorganisms or enzymes (10) 10
pest repellants or attractants (10) 10
physics (10) 10
plant growth regulators (10) 10
preservation of bodies of humans or animals or plants or partsthereof (10) 10
processes using microorganisms (10) 10
propagating, preserving or maintaining microorganisms (10) 10
trapping (10) 10
antiviral agents (9) 9
health aspects (9) 9
infections (9) 9
antiviral agents - pharmacology (7) 7
cell line (7) 7
general tagging of cross-sectional technologies spanning over several sections of the ipc (7) 7
general tagging of new technological developments (7) 7
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (7) 7
technologies for adaptation to climate change (7) 7
technologies or applications for mitigation or adaptation againstclimate change (7) 7
abridged index medicus (6) 6
biology and life sciences (6) 6
ebolavirus - drug effects (6) 6
pathogens (6) 6
replication (6) 6
research (6) 6
antiviral activity (5) 5
drug therapy (5) 5
ebola virus infections (5) 5
infection (5) 5
inhibitors (5) 5
medicine (5) 5
medicine and health sciences (5) 5
multidisciplinary sciences (5) 5
pharmacology & pharmacy (5) 5
research and analysis methods (5) 5
research article (5) 5
rna viruses (5) 5
virus replication - drug effects (5) 5
care and treatment (4) 4
cell lines (4) 4
cellular types (4) 4
female (4) 4
glycoproteins (4) 4
hemorrhagic fever viruses (4) 4
hemorrhagic fever, ebola - drug therapy (4) 4
immune cells (4) 4
macrophages (4) 4
male (4) 4
medical microbiology (4) 4
medical research (4) 4
mers-cov (4) 4
microbial pathogens (4) 4
organisms (4) 4
pathogenesis (4) 4
pathology and laboratory medicine (4) 4
viral diseases (4) 4
viral pathogens (4) 4
virus diseases (4) 4
animal cells (3) 3
antiviral (3) 3
antiviral agents - chemistry (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 03/2018, Volume 13, Issue 3, pp. e0194868 - e0194868
Middle East respiratory syndrome coronavirus (MERS-CoV) presents an emerging threat to public health worldwide by causing severe respiratory disease in humans... 
VIRAL-INFECTIONS | IMMUNE-RESPONSE | REPLICATION | MACROPHAGES | MULTIDISCIPLINARY SCIENCES | MATURE DENDRITIC CELLS | SYNDROME CORONAVIRUS INFECTION | EAST RESPIRATORY SYNDROME | CHLOROQUINE | MATURATION | T-CELLS | Macrophages - physiology | Antiviral Agents - therapeutic use | Antigen-Presenting Cells - drug effects | Coronavirus Infections - drug therapy | Humans | Cells, Cultured | Cercopithecus aethiops | Middle East Respiratory Syndrome Coronavirus - drug effects | Treatment Outcome | Drug Approval | Coronavirus Infections - immunology | Antigen-Presenting Cells - physiology | Animals | Macrophages - drug effects | Drug Evaluation, Preclinical | Monocytes - physiology | Vero Cells | Antigen presenting cells | Virulence (Microbiology) | Coronaviruses | Health aspects | Testing | Drugs | Biotechnology | Toxicity | Pathogenesis | Chloroquine | Virulence | Licenses | Cytotoxicity | Viruses | Infections | Macrophages | Chlorpromazine | Immunosuppressive agents | Ebola virus | Antiviral activity | Nosocomial infections | Public health | Antiviral agents | Antigens | Immune response | Cytokines | Dendritic cells | Health risks | Inflammation | Virology | Immune systems | Monocytes | Infectious diseases | Surveillance | Antigen-presenting cells | Respiratory diseases | West Nile virus | Cell lines | Toremifene | Human behavior | Chemokines | Viral infections | Index Medicus
Journal Article
PLoS Pathogens, ISSN 1553-7366, 09/2018, Volume 14, Issue 9, pp. e1007322 - e1007322
Lassa fever virus (LASV) is endemic in West Africa and causes severe hemorrhagic fever and sensorineural hearing loss. We identified a small molecule inhibitor... 
ALPHA-DYSTROGLYCAN | ENVELOPE GLYCOPROTEIN | MICROBIOLOGY | DEPENDENCE | NIEMANN-PICK C1 | VIROLOGY | LOW PH | PATHWAY | INFECTION | PROTEINS | CELL ENTRY | BINDING | PARASITOLOGY | Lysosome-Associated Membrane Glycoproteins - antagonists & inhibitors | Lassa virus - drug effects | Humans | Cercopithecus aethiops | Receptors, Virus - genetics | Virus Internalization - drug effects | Lysosome-Associated Membrane Glycoproteins - physiology | Receptors, Virus - physiology | Antiviral Agents - chemistry | HEK293 Cells | Protein Stability | Vero Cells | Adamantane - analogs & derivatives | Protein Structure, Tertiary | Cell Line | Viral Envelope Proteins - physiology | Adamantane - pharmacology | Antiviral Agents - pharmacology | Viral Envelope Proteins - genetics | Models, Molecular | Cholesterol - metabolism | Lassa virus - pathogenicity | Lassa virus - physiology | Animals | Host-Pathogen Interactions - genetics | Viral Envelope Proteins - chemistry | Lysosome-Associated Membrane Glycoproteins - genetics | Adamantane - chemistry | Lassa Fever - etiology | Mutation | Receptors, Virus - antagonists & inhibitors | Host-Pathogen Interactions - physiology | Lassa fever | Cell receptors | Physiological aspects | Development and progression | Genetic aspects | Research | Drug therapy | Hemorrhagic fever | Target recognition | Hematology | Glycoprotein | Viruses | Infections | Glycoproteins | Hemorrhage | Cholesterol | Fever | Medical schools | Hearing loss | Membrane proteins | Proteins | Medicine | Ebola virus | Hospitals | Inhibitors | Antiviral activity | Docking | Binding sites | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2016, Volume 11, Issue 11, pp. e0166318 - e0166318
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2018, Volume 13, Issue 3, pp. e0194880 - e0194880
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 04/2017, Volume 11, Issue 4, pp. e0005540 - e0005540
Journal Article
PLOS NEGLECTED TROPICAL DISEASES, ISSN 1935-2735, 07/2019, Volume 13, Issue 7, pp. e0007595 - e0007595
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 12/2011, Volume 204, Issue 12, pp. 1902 - 1911
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, pp. e60533 - e60533
Journal Article
13.